Search

Your search keyword '"Johan Ärnlöv"' showing total 283 results

Search Constraints

Start Over You searched for: Author "Johan Ärnlöv" Remove constraint Author: "Johan Ärnlöv" Topic medicine.medical_specialty Remove constraint Topic: medicine.medical_specialty
283 results on '"Johan Ärnlöv"'

Search Results

1. Albuminuria Testing in Hypertension and Diabetes

2. Plasma Protein Profile of Carotid Artery Atherosclerosis and Atherosclerotic Outcomes

3. A longitudinal study over 40 years to study the metabolic syndrome as a risk factor for cardiovascular diseases

4. Targeted multiplex proteomics for prediction of all-cause mortality during long-term follow-up in outpatients with peripheral arterial disease

5. Association between albuminuria, incident cardiovascular events, and mortality in persons without hypertension, diabetes, and cardiovascular disease

6. The association between length of stay in the emergency department and short-term mortality

7. Impact of the Definition of Metabolically Healthy Obesity on the Association with Incident Cardiovascular Disease

8. Plant-based diets, insulin sensitivity and inflammation in elderly men with chronic kidney disease

9. The plasma protein profile and cardiovascular risk differ between intima-media thickness of the common carotid artery and the bulb: A meta-analysis and a longitudinal evaluation

10. Association of Test Results for 33 Frequently Used Laboratory Tests with Body Mass Index (BMI)

11. Endostatin predicts mortality in patients with acute dyspnea – A cohort study of patients seeking care in emergency departments

12. Changes in Proteomic Profiles are Related to Changes in BMI and Fat Distribution During 10 Years of Aging

13. Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach

14. A screening method to spot biomarkers that may warn of serious events in a chronic disease:Illustrated by cardiological CLARICOR trial data

15. Global, regional, and national burden of stroke and its risk factors, 1990–2019 : a systematic analysis for the Global Burden of Disease Study 2019

16. Plasma calprotectin in the emergency department: a potential clinical biomarker for patients with infectious diseases

17. The genomics of heart failure: design and rationale of the HERMES consortium

18. Strong Associations Between Early Tubular Damage and Urinary Cytokine, Chemokine, and Growth Factor Levels in Elderly Males and Females

19. Development of Risk Prediction Equations for Incident Chronic Kidney Disease

20. 1051-P: Inside CKD: Modeling the Future Global Burden of Chronic Kidney Disease in Patients with Type 2 Diabetes

21. 1028-P: Inside CKD: Modeling the Clinical and Economic Impact of Routine Screening for Albuminuria in People with Type 2 Diabetes

22. 817-P: Inside CKD: Modeling the Direct Economic Burden of Concomitant Chronic Kidney Disease and Type 2 Diabetes

23. MO494INSIDE CKD: MODELLING THE ECONOMIC BURDEN OF CHRONIC KIDNEY DISEASE IN EUROPE USING PATIENT-LEVEL MICROSIMULATION

24. Life-Time Covariation of Major Cardiovascular Diseases

25. POS-323 INSIDE CKD: PROJECTING THE FUTURE BURDEN OF CHRONIC KIDNEY DISEASE IN EUROPE USING MICROSIMULATION MODELLING

26. Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction

27. Socioeconomic factors and mortality in patients with atrial fibrillation-a cohort study in Swedish primary care

28. Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease

29. Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study

30. Associations of Circulating Protein Levels With Lipid Fractions in the General Population

31. Cystatin C predicts long term mortality better than creatinine in a nationwide study of intensive care patients

32. Poorly controlled ambulatory blood pressure in outpatients with peripheral arterial disease

33. The association between BMI and 90-day mortality in patients with and without diabetes seeking care at the emergency department

34. Large-Scale Plasma Protein Profiling of Incident Myocardial Infarction, Ischemic Stroke, and Heart Failure

35. Association between Cardiorespiratory Fitness and Circulating Proteins in 50-Year-Old Swedish Men and Women : a Cross-Sectional Study

36. Proteins associated with incident metabolic syndrome in population-based cohorts

37. Impact of risk factors for major cardiovascular diseases : a comparison of life-time observational and Mendelian randomisation findings

38. Multicohort Metabolomics Analysis Discloses 9-Decenoylcarnitine to Be Associated With Incident Atrial Fibrillation

39. Plasma Protein Profile of Incident Myocardial Infarction, Ischemic Stroke, and Heart Failure in 2 Cohorts

41. Addition of cystatin C predicts cardiovascular death better than creatinine in intensive care

42. Response to letter about 'Estimated salt intake and risk of atrial fibrillation in a prospective community-based cohort'

43. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study

44. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

45. Association between kidney function, nutritional status and anthropometric measures in older people: the screening for CKD among older people across Europe (SCOPE) study

46. Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance

47. Estimated salt intake and risk of atrial fibrillation in a prospective community-based cohort

48. Kidney Disease Biomarkers Improve Heart Failure Risk Prediction in the General Population

49. Impaired kidney function is associated with lower quality of life among community-dwelling older adults : The screening for CKD among older people across Europe (SCOPE) study

50. Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial

Catalog

Books, media, physical & digital resources